Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)Jolien Onsea, Willem‐Jan Metsemakers, Jeroen Wagemans et al.|Viruses|2021Cited by 50
Alginate microbeads and hydrogels delivering meropenem and bacteriophages to treat Pseudomonas aeruginosa fracture-related infectionsBaixing Chen, Willem‐Jan Metsemakers, T. Fintan Moriarty et al.|Journal of Controlled Release|2023Cited by 38
Combination of bacteriophages and vancomycin in a co-delivery hydrogel for localized treatment of fracture-related infectionsBaixing Chen, T. Fintan Moriarty, Luis Ponce Benavente et al.|npj Biofilms and Microbiomes|2024Cited by 17
Evaluating the safety, pharmacokinetics and efficacy of phage therapy in treating fracture-related infections with multidrug-resistant Staphylococcus aureus: intravenous versus local application in sheepChristian Peez, T. Fintan Moriarty, Daniel Arens et al.|Frontiers in Cellular and Infection Microbiology|2025Cited by 12
Optimization of bacteriophage therapy for difficult-to-treat musculoskeletal infections: a bench-to-bedside perspectiveLaura Bessems, Jolien Onsea, Vera van Noort et al.|Frontiers in Cellular and Infection Microbiology|2024Cited by 4